Covalon Announces New Breakthrough Antimicrobial Technology Formulated to Kill The COVID-19 Virus

Covalon Technologies announces its new breakthrough antimicrobial technology formulated to kill the COVID-19 virus and other viruses, bacteria, and pathogens.

PHARMASEAL Supports Life Science Businesses by Offering No Cost CTMS for COVID-19 Clinical Trials

PHARMASEAL International, provider of clinical trials management systems has announced that it will offer the Engility CTMS solution at no cost for COVID-19 Coronavirus clinical trials.

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

J&J announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020; the significant expansion of the existing partnership between the Janssen Pharma...

Chembio Announces Launch of DPP COVID-19 Serological Point-of-Care Test

Chembio Diagnostics, Inc announced the U.S. launch of the rapid DPP COVID-19 serological point-of-care test for the detection of IgM and IgG antibodies.

Mologic and partners begin validation process for COVID-19 point-of-need diagnostic test

Mologic Ltd announced that it has initiated early validation of COVID-19 point-of-need diagnostic tests with the Liverpool School..

First-ever Dachser Mexico international charter airlifts over 3 million surgical masks to Germany

Dachser Mexico announced that it provided air transportation of more than three million surgical and respiratory masks to Germany to help combat...

Cobra Biologics announces collaboration to develop Covid-19 DNA vaccine

Cobra Biologics and the Karolinska Institutet (KI) have been awarded €3 million in emergency funding to take a DNA vaccine for Covid-19 through phase...

GigaGen Works to Develop Passive, Convalescent COVID-19 Therapy

GigaGen is developing a recombinant polyclonal antibody therapy to treat COVID-19. First uses are envisioned as treatments for severely ill coronavirus...

Cobra Bio Secures $3.3 Million to Develop DNA Vaccine Against COVID-19

U.K.-based Cobra Biologics and noted medical university the Karolinska Institute, which is based in Sweden, secured millions in emergency funding from Horizon 2020 to support research...

ideaPoint and WideTrial Launch Global Expanded Access Platform for COVID-19 Medicines

ideaPoint announced a strategic partnership with clinical data company WideTrial to facilitate greater access to investigational medicines for physicians and patients dealing with COVID-19 worldwide.